Infectious diarrhea Medical Services in China

Infectious diarrhea is an acute gastrointestinal disorder characterized by frequent, loose, or watery stools caused by pathogenic microorganisms—including bacteria (e.g., Salmonella, Campylobacter, Shigella, Escherichia coli), viruses (e.g., norovirus, rotavirus, adenovirus), and parasites (e.g., Giardia lamblia, Cryptosporidium)—that invade the intestinal mucosa or produce enterotoxins. Pathogenesis involves either direct mucosal invasion leading to inflammation and epithelial damage, or toxin-mediated disruption of ion transport (e.g., cholera toxin activating adenylate cyclase → chloride secretion → osmotic water loss). In some cases, post-infectious complications such as reactive arthritis, Guillain-Barré syndrome (linked to Campylobacter), or irritable bowel syndrome may arise. Globally, infectious diarrhea remains a leading cause of morbidity and mortality—especially among children under five—accounting for an estimated 1.6 million deaths annually, with over 90% occurring in low- and middle-income countries. In China, incidence peaks during summer and early autumn due to warmer temperatures favoring bacterial proliferation and increased consumption of raw or undercooked foods. Risk factors include poor sanitation, inadequate hand hygiene, contaminated food/water, travel to endemic regions, immunocompromised status (e.g., HIV, chemotherapy), antibiotic use (predisposing to Clostridioides difficile infection), and age extremes (infants and elderly). While most cases are self-limiting, severe dehydration, electrolyte imbalances (hypokalemia, metabolic acidosis), acute kidney injury, and sepsis can occur—particularly in vulnerable populations. Beyond physical consequences, infectious diarrhea significantly impairs quality of life: it disrupts work and school attendance, causes anxiety about recurrence or transmission, strains caregiver resources, and may lead to nutritional deficits and growth faltering in children. Chronic or recurrent episodes may erode confidence in daily activities, reduce social engagement, and contribute to long-term gastrointestinal hypersensitivity. Early recognition, appropriate rehydration (oral or intravenous), targeted antimicrobial therapy when indicated (e.g., for dysentery or systemic infection), and supportive care remain cornerstones of management. Prevention emphasizes food safety education, access to clean water, vaccination (e.g., rotavirus vaccine), and antimicrobial stewardship to curb resistance.

Infectious diarrhea—defined as acute or subacute diarrheal illness caused by bacterial, viral, parasitic, or toxin-mediated pathogens—is a common gastrointestinal disorder managed primarily within gastroenterology departments. In China, the Digestive Medicine Department (Gastroenterology) adopts an evidence-based, stratified approach integrating conservative management, targeted pharmacotherapy, and rare surgical intervention when complications arise. Treatment is tailored to pathogen identification (when feasible), clinical severity, host factors (e.g., age, immunocompromise, comorbidities), and epidemiologic context.

Conservative treatment forms the cornerstone of management for most cases—particularly mild-to-moderate infectious diarrhea. Oral rehydration therapy (ORT) remains the single most effective life-saving intervention. The World Health Organization–recommended low-osmolarity oral rehydration solution (ORS) containing 75 mmol/L sodium, 75 mmol/L glucose, 20 mmol/L potassium, and 10 mmol/L citrate is widely used in Chinese hospitals and community health centers. ORT restores electrolyte deficits, corrects mild-to-moderate dehydration, and reduces stool volume and duration. For infants and young children, continued breastfeeding or age-appropriate lactose-tolerant formula is strongly encouraged; dietary resumption with easily digestible foods (e.g., rice, bananas, applesauce, toast—'BRAT' diet adjunct) is initiated within 4–6 hours of rehydration, avoiding fasting. Probiotics—including Lactobacillus rhamnosus GG, Saccharomyces boulardii, and Bifidobacterium triple viable capsules (a standardized formulation approved by China’s NMPA)—are routinely prescribed for 5–7 days in pediatric and adult patients to shorten diarrheal duration by approximately 24 hours and reduce persistent diarrhea risk. Zinc supplementation (10–20 mg elemental zinc daily for 10–14 days) is standard in children under five, per national guidelines, due to its proven efficacy in reducing recurrence and severity.

Pharmacologic intervention is selective—not routine. Antibiotics are reserved for specific indications: confirmed or highly suspected invasive bacterial pathogens (e.g., Shigella, Campylobacter jejuni, invasive Escherichia coli, Salmonella in high-risk groups), systemic toxicity (fever >38.5°C, tachycardia, leukocytosis), immunosuppression, or prolonged symptoms (>72 hours with worsening). First-line agents in China include fluoroquinolones (e.g., levofloxacin 500 mg once daily for adults, contraindicated in children <18 years) and azithromycin (500 mg daily × 3 days), particularly for Campylobacter or suspected macrolide-sensitive strains. For Clostridioides difficile infection (CDI), vancomycin (125 mg orally four times daily) or fidaxomicin (200 mg twice daily) is administered, with fecal microbiota transplantation (FMT) increasingly available at tertiary centers for recurrent CDI. Antiparasitics—such as nitazoxanide (500 mg twice daily × 3 days for Cryptosporidium or Giardia) or tinidazole (2 g single dose for Giardia)—are deployed following microscopic or PCR-confirmed diagnosis. Antimotility agents (e.g., loperamide) are cautiously used only in non-febrile, non-dysenteric adults without systemic signs; they are contraindicated in suspected Shiga-toxin–producing E. coli (STEC) or C. difficile due to risk of toxic megacolon or HUS. Antiemetics (e.g., ondansetron) may be considered for severe nausea/vomiting impeding ORT adherence.

Surgical treatment is exceedingly rare and strictly limited to life-threatening complications. These include toxic megacolon (typically secondary to C. difficile or severe ulcerative colitis mimicking infection), perforation, fulminant colitis unresponsive to maximal medical therapy, or ischemic bowel secondary to hypovolemic shock. Emergency colectomy—often subtotal with end ileostomy—may be required in refractory toxic megacolon with hemodynamic instability or radiographic evidence of free air. Laparoscopic exploration is increasingly utilized in advanced centers for diagnostic clarification in atypical presentations. Surgical decision-making involves multidisciplinary collaboration between gastroenterologists, colorectal surgeons, and critical care specialists, with emphasis on preoperative optimization of fluid, electrolyte, and septic parameters.

China offers distinct advantages in infectious diarrhea management. First, the nationwide integrated surveillance system—led by the Chinese Center for Disease Control and Prevention (China CDC)—enables rapid pathogen detection via multiplex PCR panels (e.g., GI Pathogen Panels detecting 22+ bacteria, viruses, and parasites) within 4–6 hours in Class III-A hospitals. Second, standardized clinical pathways endorsed by the Chinese Society of Gastroenterology ensure consistent application of ORT, antibiotic stewardship protocols, and probiotic regimens across urban and rural settings. Third, China’s robust domestic pharmaceutical industry supplies high-quality, affordable generic antibiotics, zinc, ORS, and probiotics—reducing treatment delays and out-of-pocket costs. Fourth, telemedicine platforms (e.g., WeDoctor, Ping An Good Doctor) facilitate remote triage and ORT guidance for rural populations, improving early intervention. Finally, large-scale public health initiatives—including sanitation infrastructure upgrades, food safety enforcement (e.g., 'Food Safety Law' implementation), and nationwide handwashing campaigns—have contributed to a 35% decline in all-cause diarrheal mortality among children under five since 2010.

Recovery advice emphasizes sustained hydration, nutritional rehabilitation, and infection prevention. Patients should continue oral fluids (water, diluted fruit juices, clear broths) until stool frequency normalizes—typically 48–72 hours after symptom resolution. A gradual return to balanced nutrition—including lean protein, complex carbohydrates, and soluble fiber (e.g., oats, cooked carrots)—is advised over 3–5 days; high-fat, spicy, or lactose-rich foods should be avoided for ≥7 days post-recovery, especially if lactase deficiency is suspected. Hand hygiene (soap-and-water washing for ≥20 seconds, especially after toileting and before eating) and safe food handling (thorough cooking of meats, avoidance of raw shellfish, refrigeration of leftovers <2 hours) are critical to prevent reinfection and household transmission. Household contacts should disinfect surfaces with chlorine-based solutions (≥1000 ppm). Follow-up is recommended if symptoms persist beyond 7 days, recur within 2 weeks, or if red flags emerge—including hematochezia, fever >39°C, severe abdominal pain, or signs of dehydration (e.g., oliguria, dizziness, sunken eyes). Vaccination counseling (e.g., rotavirus vaccine for infants, typhoid conjugate vaccine for travelers) is integrated into discharge planning in endemic regions. With timely, appropriate management, >95% of uncomplicated infectious diarrhea cases resolve fully within one week without sequelae.